415 related articles for article (PubMed ID: 33460021)
41. Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis.
Eder L; Chandran V; Pellet F; Shanmugarajah S; Rosen CF; Bull SB; Gladman DD
Ann Rheum Dis; 2012 Jan; 71(1):50-5. PubMed ID: 21900282
[TBL] [Abstract][Full Text] [Related]
42. HLA-C and TNF gene polymorphisms are associated with psoriasis in Brazilian patients.
Cardili RN; Deghaide NS; Mendes-Junior CT; Donadi EA; Souza CS
Int J Dermatol; 2016 Jan; 55(1):e16-22. PubMed ID: 26470763
[TBL] [Abstract][Full Text] [Related]
43. HLA-C and guttate psoriasis.
Mallon E; Bunce M; Savoie H; Rowe A; Newson R; Gotch F; Bunker CB
Br J Dermatol; 2000 Dec; 143(6):1177-82. PubMed ID: 11122018
[TBL] [Abstract][Full Text] [Related]
44. Age at disease onset: a key factor for understanding psoriatic disease.
Queiro R; Tejón P; Alonso S; Coto P
Rheumatology (Oxford); 2014 Jul; 53(7):1178-85. PubMed ID: 24273020
[TBL] [Abstract][Full Text] [Related]
45. The MICA-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to the development of psoriatic arthritis and is independent of the association of Cw*0602 in psoriasis.
Gonzalez S; Martinez-Borra J; Torre-Alonso JC; Gonzalez-Roces S; Sanchez del Río J; Rodriguez Pérez A; Brautbar C; López-Larrea C
Arthritis Rheum; 1999 May; 42(5):1010-6. PubMed ID: 10323458
[TBL] [Abstract][Full Text] [Related]
46. SPR1 gene near HLA-C is unlikely to be a psoriasis susceptibility gene.
Chang YT; Tsai SF; Lin MW; Liu HN; Lee DD; Shiao YM; Chin PJ; Wang WJ
Exp Dermatol; 2003 Jun; 12(3):307-14. PubMed ID: 12823445
[TBL] [Abstract][Full Text] [Related]
47. Potential Differences in the Cardiometabolic Risk Profile of Patients with Psoriatic Disease according to Their HLA-C∗06 Status.
Queiro R; Coto-Segura P; Braña I; Pino M; Burger S
Biomed Res Int; 2022; 2022():1451193. PubMed ID: 35127937
[TBL] [Abstract][Full Text] [Related]
48. HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis.
Dand N; Duckworth M; Baudry D; Russell A; Curtis CJ; Lee SH; Evans I; Mason KJ; Alsharqi A; Becher G; Burden AD; Goodwin RG; McKenna K; Murphy R; Perera GK; Rotarescu R; Wahie S; Wright A; Reynolds NJ; Warren RB; Griffiths CEM; Smith CH; Simpson MA; Barker JN; ; ;
J Allergy Clin Immunol; 2019 Jun; 143(6):2120-2130. PubMed ID: 30578879
[TBL] [Abstract][Full Text] [Related]
49. The molecular basis for reactivity of anti-Cw1 and anti-Cw3 alloantisera with HLA-B46 haplotypes.
Zemmour J; Gumperz JE; Hildebrand WH; Ward FE; Marsh SG; Williams RC; Parham P
Tissue Antigens; 1992 May; 39(5):249-57. PubMed ID: 1384166
[TBL] [Abstract][Full Text] [Related]
50. Nailing down the genetic and immunological basis for psoriatic disease.
McGonagle D; Palmou Fontana N; Tan AL; Benjamin M
Dermatology; 2010; 221 Suppl 1():15-22. PubMed ID: 20733311
[TBL] [Abstract][Full Text] [Related]
51. Human Leukocyte Antigen-Class I Alleles and the Autoreactive T Cell Response in Psoriasis Pathogenesis.
Prinz JC
Front Immunol; 2018; 9():954. PubMed ID: 29760713
[TBL] [Abstract][Full Text] [Related]
52. Distinct clinical differences between HLA-Cw*0602 positive and negative psoriasis patients--an analysis of 1019 HLA-C- and HLA-B-typed patients.
Gudjonsson JE; Karason A; Runarsdottir EH; Antonsdottir AA; Hauksson VB; Jónsson HH; Gulcher J; Stefansson K; Valdimarsson H
J Invest Dermatol; 2006 Apr; 126(4):740-5. PubMed ID: 16439971
[TBL] [Abstract][Full Text] [Related]
53. Cross-phenotype association mapping of the MHC identifies genetic variants that differentiate psoriatic arthritis from psoriasis.
Bowes J; Ashcroft J; Dand N; Jalali-Najafabadi F; Bellou E; Ho P; Marzo-Ortega H; Helliwell PS; Feletar M; Ryan AW; Kane DJ; Korendowych E; Simpson MA; Packham J; McManus R; Brown MA; Smith CH; Barker JN; McHugh N; FitzGerald O; Warren RB; Barton A
Ann Rheum Dis; 2017 Oct; 76(10):1774-1779. PubMed ID: 28821532
[TBL] [Abstract][Full Text] [Related]
54. HLA-Cw*0602 associates with a twofold higher prevalence of positive streptococcal throat swab at the onset of psoriasis: a case control study.
Mallbris L; Wolk K; Sánchez F; Ståhle M
BMC Dermatol; 2009 May; 9():5. PubMed ID: 19480679
[TBL] [Abstract][Full Text] [Related]
55. Genetics of psoriasis and psoriatic arthritis.
Mathieu A; Cauli A; Vacca A; Mameli A; Passiu G; Porru G; Piga M; Ibba V; Mura V; Sanna S
Reumatismo; 2007; 59 Suppl 1():25-7. PubMed ID: 17828355
[TBL] [Abstract][Full Text] [Related]
56. Allele-specific cytokine responses at the HLA-C locus: implications for psoriasis.
Hundhausen C; Bertoni A; Mak RK; Botti E; Di Meglio P; Clop A; Laggner U; Chimenti S; Hayday AC; Barker JN; Trembath RC; Capon F; Nestle FO
J Invest Dermatol; 2012 Mar; 132(3 Pt 1):635-41. PubMed ID: 22113476
[TBL] [Abstract][Full Text] [Related]
57. Biomarkers of disease progression in people with psoriasis: a scoping review.
Ramessur R; Corbett M; Marshall D; Acencio ML; Barbosa IA; Dand N; Di Meglio P; Haddad S; Jensen AHM; Koopmann W; Mahil SK; Ostaszewski M; Rahmatulla S; Rastrick J; Saklatvala J; Weidinger S; Wright K; Eyerich K; Ndlovu M; Barker JN; Skov L; Conrad C; Smith CH;
Br J Dermatol; 2022 Oct; 187(4):481-493. PubMed ID: 35482474
[TBL] [Abstract][Full Text] [Related]
58. Clinical and genetic aspects of psoriatic arthritis "sine psoriasis".
Scarpa R; Cosentini E; Manguso F; Oriente A; Peluso R; Atteno M; Ayala F; D'Arienzo A; Oriente P
J Rheumatol; 2003 Dec; 30(12):2638-40. PubMed ID: 14719207
[TBL] [Abstract][Full Text] [Related]
59. Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study.
Costanzo A; Bianchi L; Flori ML; Malara G; Stingeni L; Bartezaghi M; Carraro L; Castellino G;
Br J Dermatol; 2018 Nov; 179(5):1072-1080. PubMed ID: 29704432
[TBL] [Abstract][Full Text] [Related]
60. Psoriatic arthritis sine psoriasis.
Olivieri I; Padula A; D'Angelo S; Cutro MS
J Rheumatol Suppl; 2009 Aug; 83():28-9. PubMed ID: 19661535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
